| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 52.191 | 74.180 | 48.199 | 137.548 | 56.805 | 37.963 | 39.754 | 32.301 | 46.955 |
| Total Income - EUR | - | 52.191 | 75.059 | 48.199 | 141.842 | 58.245 | 38.764 | 39.754 | 32.354 | 46.956 |
| Total Expenses - EUR | - | 1.003 | 17.226 | 7.839 | 1.632 | 3.276 | 10.535 | 14.783 | 11.563 | 12.359 |
| Gross Profit/Loss - EUR | - | 51.188 | 57.833 | 40.361 | 140.210 | 54.969 | 28.228 | 24.972 | 20.791 | 34.597 |
| Net Profit/Loss - EUR | - | 49.622 | 55.581 | 38.915 | 135.955 | 53.306 | 27.205 | 23.803 | 16.893 | 28.594 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Interventional Cardioresearch Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 2.090 | 1.628 | 1.181 | 31.131 | 22.804 | 18.109 | 10.481 | 2.891 |
| Current Assets | - | 50.890 | 106.677 | 96.097 | 160.787 | 125.570 | 157.699 | 36.388 | 13.473 | 33.054 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 3.413 | 36.105 | 50.863 | 74.774 | 71.748 | 26.965 | 4.313 | 3.715 |
| Cash | - | 50.890 | 103.264 | 59.992 | 109.924 | 50.796 | 85.951 | 9.423 | 9.160 | 29.338 |
| Shareholders Funds | - | 49.666 | 104.407 | 93.519 | 135.997 | 53.347 | 79.369 | 23.844 | 17.984 | 28.642 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.223 | 4.360 | 4.284 | 26.132 | 103.353 | 101.134 | 30.654 | 5.970 | 7.745 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Interventional Cardioresearch Srl